Replies to post #42686 on Propanc Biopharma Inc (PPCB)

[elkhunter]

If the second wave of Covid-19 is as bad as the first wave investors positions in the company will be totally wiped out. Doubt we'll ever get back to the pre-pandemic level of $.0449

How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are Increasingly Vulnerable to the COVID-19 Global Pandemic.

Propanc Biopharma's stock was trading at $0.0449 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PPCB shares have decreased by 94.4321% and is now trading at $0.0025.

If this is how Propanc Biopharma is joining the fight with cancer patients they're better off fending for themselves.